Teprenone

Teprenone
Clinical data
Trade names	Selbex
AHFS/Drugs.com	International Drug Names
ATC code	A02BX15 (WHO) QA02BX15 (WHO);
Legal status
Legal status	In general: ℞ (Prescription only);
Identifiers
	IUPAC name (5E,9E,13E)-6,10,14,18-tetramethylnonadeca-5,9,13,17-tetraen-2-one;
CAS Number	6809-52-5;
PubChem CID	5282199;
DrugBank	DB15955 ;
ChemSpider	29787024;
UNII	S8S8451A4O;
KEGG	D01827 ;
ChEBI	CHEBI:31649;
ChEMBL	ChEMBL79686;
CompTox Dashboard (EPA)	DTXSID901166719 ;
Chemical and physical data
Formula	C23H38O
Molar mass	330.556 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CC(C)=CCC\C(C)=C\CC\C(C)=C\CC\C(C)=C\CCC(C)=O;
	InChI InChI=1S/C23H38O/c1-19(2)11-7-12-20(3)13-8-14-21(4)15-9-16-22(5)17-10-18-23(6)24/h11,13,15,17H,7-10,12,14,16,18H2,1-6H3/b20-13 ,21-15 ,22-17 ; Key:HUCXKZBETONXFO-NJFMWZAGSA-N;
	(verify)

Teprenone (or geranylgeranylacetone), sold under the brand name Selbex,^[1] is a medication used for the treatment of gastric ulcers.^[2]

References

^ Liu X, Jia B, Lin S (January 1996). "[Teprenone in the treatment of chronic superficial gastritis, a multicentre study]". Zhonghua Nei Ke Za Zhi (in Chinese). 35 (1): 12–4. PMID 9275638.
^ Kitahata H, Nozaki J, Kawahito S, Tomino T, Oshita S (September 2008). "Low-dose sevoflurane inhalation enhances late cardioprotection from the anti-ulcer drug geranylgeranylacetone". Anesth. Analg. 107 (3): 755–61. doi:10.1213/ane.0b013e31817f0e61. PMID 18713879. S2CID 19387865.

This article about an alkene is a stub. You can help Wikipedia by expanding it.

This drug article relating to the gastrointestinal system is a stub. You can help Wikipedia by expanding it.

v t e Drugs for peptic ulcer and GERD/GORD (A02B)
H₂ antagonists ("-tidine")	Cimetidine Famotidine Lafutidine Lavoltidine (loxtidine) Nizatidine Ranitidine^#‡ Roxatidine
Prostaglandins (E)/ analogues ("-prost-")	Misoprostol Enprostil
Proton-pump inhibitors ("-prazole")	Azeloprazole Dexlansoprazole Esomeprazole Ilaprazole Lansoprazole Omeprazole^# Pantoprazole Picoprazole Rabeprazole Tenatoprazole Timoprazole
Potassium-competitive acid blockers ("-prazan")	Linaprazan Revaprazan Soraprazan Vonoprazan
Others	Aceglutamide aluminum Acetoxolone Alginic acid Arbaclofen placarbil Bismuth subcitrate Carbenoxolone Cetraxate Gefarnate Irsogladine Lesogaberan Pirenzepine Proglumide Rebamipide Sucralfate Sulglicotide Telenzepine Teprenone Troxipide Zinc L-carnosine Zolimidine
Combinations	Bismuth subcitrate/metronidazole/tetracycline Omeprazole/amoxicillin/rifabutin Vonoprazan/amoxicillin Vonoprazan/amoxicillin/clarithromycin
See also: Helicobacter pylori* eradication protocols*
^#WHO-EM ^‡Withdrawn from market Clinical trials: ^†Phase III ^§Never to phase III